首页> 外文期刊>Sleep & breathing =: Schlaf & Atmung >Ambulatory screening tool for sleep apnea: analyzing a single-lead electrocardiogram signal (ECG)
【24h】

Ambulatory screening tool for sleep apnea: analyzing a single-lead electrocardiogram signal (ECG)

机译:用于睡眠呼吸暂停的动态筛查工具:分析单引灯心电图信号(ECG)

获取原文
获取原文并翻译 | 示例
           

摘要

Study objective The goal was to determine the utility and accuracy of automated analysis of single-lead electrocardiogram (ECG) data using two algorithms, cardiopulmonary coupling (CPC), and cyclic variation of heart rate (CVHR) to identify sleep apnea (SA). Methods The CPC-CVHR algorithms were applied to identify SA by analyzing ECG from diagnostic polysomnography (PSG) from 47 subjects. The studies were rescored according to updated AASM scoring rules, both manually by a certified technologist and using an FDA-approved automated scoring software, Somnolyzer (Philips Inc., Monroeville, PA). The CPC+CVHR output of Sleep Quality Index (SQI), Sleep Apnea Indicator (SAI), elevated low frequency coupling broadband (eLFC~(BB)) and elevated low frequency coupling narrow-band (eLFC~(NB)) were compared to the manual and automated scoring of apnea hypopnea index (AHI). Results A high degree of agreement was noted between the CPC-CVHR against both the manually rescored AHI and the computerized scored AHI to identify patients with moderate and severe sleep apnea (AHI >?15). The combined CPC+CVHR algorithms, when compared to the manually scored PSG output presents sensitivity 89%, specificity 79%, agreement 85%, PPV (positive predictive value) 0.86 and NPV (negative predictive value) 0.83, and substantial Kappa 0.70. Comparing the output of the automated scoring software to the manual scoring demonstrated sensitivity 93%, specificity 79%, agreement 87%, PPV 0.87, NPV 0.88, and substantial Kappa 0.74. Conclusion The CPC+CVHR technology performed as accurately as the automated scoring software to identify patients with moderate to severe SA, demonstrating a clinically powerful tool that can be implemented in various clinical settings to identify patients at risk for SA. Trial registration NCT01234077.
机译:研究目标是使用两种算法,心肺耦合(CPC)和心率(CVHR)的循环变异来确定单引灯心电图(ECG)数据的自动分析的实用性和准确性,并进行心率(CVHR)以识别睡眠呼吸暂停(SA)。方法通过从47个受试者分析来自诊断多肌气摄影(PSG)的ECG,应用CPC-CVHR算法以识别SA。根据经认证的技术专家手动,根据更新的ASAF评分规则并使用FDA批准的自动评分软件,Somnolyzer(Philips Inc.,Monroeville,PA)根据更新的ASAF评分规则进行了补充。比较睡眠质量指数(SQI)的CPC + CVHR输出,睡眠呼吸暂停指示器(SAI),升高的低频耦合宽带(ELFC〜(BB))和高频耦合窄带(ELFC〜(NB))进行了高频耦合窄带(ELFC〜(NB))呼吸暂停缺氧率(AHI)的手动和自动评分。结果CPC-CVHR与手动重新激进的AHI和计算机化得分的AHI之间指出了高度协议,以识别睡眠中度和严重睡眠呼吸暂停(AHI> 15)的患者。组合的CPC + CVHR算法,与手动均衡的PSG输出相比显示敏感性89%,特异性79%,协议85%,PPV(阳性预测值)0.86和NPV(否定预测值)0.83,实质性Kappa 0.70。将自动评分软件的输出与手动评分进行比较,表明灵敏度93%,特异性79%,协议87%,PPV 0.87,NPV 0.88和大量κ0.74。结论CPC + CVHR技术尽可能准确地作为自动评分软件,以识别中度至严重SA的患者,展示可以在各种临床环境中实施的临床强大的工具,以确定患者的患者。试验登记NCT01234077。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号